Tourmaline Bio, Inc.
TRML
$23.31
$0.251.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.53% | -3.31% | -10.20% | -15.38% | -31.37% |
| Total Depreciation and Amortization | 0.00% | 33.33% | -10.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.76% | 482.23% | 54.40% | 13.08% | -364.36% |
| Change in Net Operating Assets | 230.99% | -65.71% | 153.92% | -8,521.21% | 98.18% |
| Cash from Operations | 6.53% | -3.78% | 10.90% | -30.19% | -20.67% |
| Capital Expenditure | 22.22% | 0.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.15% | 58.24% | 240.22% | -15.44% | 94.64% |
| Cash from Investing | -37.15% | 58.27% | 240.15% | -15.44% | 94.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.51% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 100.00% | -133.33% | -200.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.39% | 18,833.33% | -200.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.99% | 207.15% | 87.19% | -24.88% | 33.70% |